Publications

Export 5114 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C [D] E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
D
El-Daleel, M. S., O. Mahgoub, A. L. Elshafie, and A. Mahgoub, "Dead-time compensation via adaptive lookup table reconstruction for low-speed operation", 9th IEEE International Conference on Power Electronics, Drives and Energy Systems, PEDES 2020, Jaipur, India, 16-19 Dec., 2020.
El-Daleel, M. S., O. Mahgoub, A. L. Elshafie, and A. Mahgoub, "Dead-time Compensation via Adaptive Lookup Table Reconstruction for Low-Speed Operation", 2020 IEEE International Conference on Power Electronics, Drives and Energy Systems (PEDES), pp. 1 - 6, 16-19 Dec. 2020. Abstract

n/a

Ouannas, A., G. Grassi, A. T. Azar, A. G. Radwan, C. Volos, V. - T. Pham, T. Ziar, I. M. Kyprianidis, and I. N. Stouboulos, "Dead-beat synchronization control in discrete-time chaotic systems", Modern Circuits and Systems Technologies (MOCAST), 2017 6th International Conference on: IEEE, pp. 1–4, 2017. Abstract
n/a
El-Zawawy, M. A., "Dead code elimination based pointer analysis for multithreaded programs", Journal of the Egyptian Mathematical Society, vol. 20, no. 1, pp. 28-37, January, 2012. AbstractDead code elimination based pointer analysis for multithreaded programs.pdf

This paper presents a new approach for optimizing multitheaded programs with pointer constructs. The approach has applications in the area of certified code (proof-carrying code) where a justification or a proof for the correctness of each optimization is required. The optimization meant here is that of dead code elimination. Towards optimizing multithreaded programs the paper presents a new operational semantics for parallel constructs like join-fork constructs, parallel loops, and conditionally spawned threads. The paper also presents a novel type system for flow-sensitive pointer analysis of multithreaded programs. This type system is extended to obtain a new type system for live-variables analysis of multithreaded programs. The live-variables type system is extended to build the third novel type system, proposed in this paper, which carries the optimization of dead code elimination. The justification mentioned above takes the form of type derivation in our approach.

Abdel-Mageed, A. M., D. Widmann, S. E. Olesen, I. Chorkendorff, and J. R. Behm, "Deactivation of supported Ru catalysts during the Selective CO Methanation (SelMeth): Separating structural and adlayer effects ", Chemical Reactions at Surfaces, (GRS) Gordon Research Seminar, Renaissance Tuscany Il Ciocco Lucca (Barga), Italy, 04.02.2017. jrs_deactivation_of_supported_ru_catalysts.pdf
El-Moemen, A. A., A. M. Abdel-Mageed, M. Parlinska-Wojtan, R. J. Behm, and G. Kučerová, "Deactivation of Au/CeO 2 catalysts during CO oxidation: Influence of pretreatment and reaction conditions", Journal of Catalysis, vol. 341, pp. 160-179, 2016.
Galal, S. M., "Deacidification of lampante olive oil", Egyptian J. of Nutrition, vol. 23, no. 2: The Egyptian Nutrition Society, pp. 133–156, 2008. Abstract
n/a
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018 Jan. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018 Jan. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabi, A. H. Abdelmaksoud, H. I. Shoushaa, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology & Hepatology, vol. 30, issue 1, pp. 39–43, 2018.
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, and T. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology and Hepatology, vol. 30, issue 1, pp. 39-43, 2018.
Geraniotis, E., and M. M. Khairy, De-modulation of MOK (M-ary orthogonal modulation), , 2005. Abstract
n/a
Geraniotis, E., and M. M. Khairy, De-modulation of MOK (M-ary orthogonal modulation), , 2007. Abstract
n/a
Geraniotis, E., and M. M. Khairy, De-modulation of MOK (M-ary orthogonal modulation), , 2007. Abstract
n/a
Karim, G. A., "DE NUEVO, SOBRE LA ESPAÑA MUSULMANA: EL OTRO SIGLO DE ORO ESPAÑOL", Hermes, vol. 2, issue 4, pp. 111-167, 2013. gamal_abdel_karim.pdf
Afifi, H. H., R. Fukai, N. Miyake, A. G. A. el Din, M. M. Eid, O. M. Eid, M. M. Thomas, T. E. H. Badry, A. M. S. Tosson, G. M. H. Abdel-Salam, et al., "De Novo 17q24.2–q24.3 Microdeletion Presenting with Generalized Hypertrichosis Terminalis, Gingival Fibromatous Hyperplasia, and Distinctive Facial Features", American Journal of Medical Genetics Part A, vol. 167, issue 10, pp. 2418-2424, 2015. de_novo_17q24.2-q24.3_microdeletion_presenting_2.pdf
Machhour, H., "De la terminologie du Coran à une réflexion sur l'acte de traduire. L'exemple du couple mort/vie.", Bulletin de la Faculté de Lettres, vol. 2, issue 1, pp. 7-92, 2007.
Gad El Hak, F., "De la representation de la premiere dame de france", Il ritratto e il potere, Pisa, Pacini Editore Srl, 2017. Abstract

Cette recherche s’inscrit dans le cadre d’une réflexion plus vaste
portant sur l’évolution des mentalités et sur l’histoire des représentations
en France. A partir de l’exemple de l’image de la Première
dame, il s’agira non seulement d’en dégager les constantes et les
variantes, et ce, dès l’avènement de la Vème République, mais aussi
d’essayer de cerner l’évolution du statut de la femme, et de mieux
saisir le brouillage des frontières entre sphère publique et sphère
privée1. A travers l’analyse menée, nous tenterons de dégager les
stratégies qui régissent le discours médiatique étudié, et d’établir
des liens entre ces stratégies et les logiques commerciales.

HAK, M. G. A. D. E. L., "DE LA CARICATURE EGYPTIENNE", RIDICULOSA, pp. 431-460, 2013.
Beard, J., and A. R. H. R. Collaboration, "DDT and human health", Science of the total environment, vol. 355, issue 1-3: Elsevier, pp. 78-89, 2006. Abstract
n/a
mazen, "dd", ijiijij, 2010.
Wahby, M. A., K. MOSTAFA, and A. M. Darwish, "DCT-based MPEG-2 programmable coprocessor [4674-03]", PROCEEDINGS-SPIE THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING: International Society for Optical Engineering; 1999, pp. 14–20, 2002. Abstract
n/a
Wahby, M. A., K. MOSTAFA, and A. M. Darwish, "DCT-based MPEG-2 programmable coprocessor [4674-03]", PROCEEDINGS-SPIE THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING: International Society for Optical Engineering; 1999, pp. 14–20, 2002. Abstract
n/a
Wahby, M. A., K. MOSTAFA, and A. M. Darwish, "DCT-based MPEG-2 programmable coprocessor [4674-03]", PROCEEDINGS-SPIE THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING: International Society for Optical Engineering; 1999, pp. 14-20, 2002. Abstract
n/a
Tourism